Get complete access to comprehensive company data for Shin Nippon Biomedical Laboratories India Private Limited.
Complete Report
One-time • Full access
Credit Plan
Pay as you go • Instant
Processing your request...
Downloading your report...
Success
Request Company Screening
Shin Nippon Biomedical Laboratories India Private Limited
Once your screening request is processed, you will receive a notification and the complete report will be available in PDF format for download from your account dashboard.
₹ 190.00 lakh
₹ 190.00 lakh
18 Oct 2007
31 Mar 2015
Shin Nippon Biomedical Laboratories India Private Limited is an Indian private limited company incorporated on 18 Oct 2007. The company's registered office is situated in Bangaluru, Karnataka, India.
The current status of Shin Nippon Biomedical Laboratories India Private Limited is Dissolved (Liquidated). The company has filed its annual returns and financial statements up to 31 Mar 2015 (FY 2014-2015).
Shin Nippon Biomedical Laboratories India Private Limited is a company limited by shares with an authorized capital of ₹190.00 lakh and a paid-up capital of ₹190.00 lakh as per the records maintained by the Ministry of Corporate Affairs (MCA).
Shin Nippon Biomedical Laboratories India Private Limited has 2 directors. The directors of the company include Suchi Agarwal, Amit Agarwal.
The registered office of Shin Nippon Biomedical Laboratories India Private Limited is located at Level-2, Park Square, No.150 36Th Cross, Jayanagar 7Th Block Bengaluru Karnataka 560082 India in Bangaluru, Karnataka, India.
- CIN/LLPIN/FCRN: U74130KA2007FTC044159
- Legal Name: Shin Nippon Biomedical Laboratories India Private Limited
- ROC Code: Roc Bangalore
- Company No.: 044159
- Company Category: Company Limited By Shares
- Company Sub Category: Subsidiary Of Company Incorporated Outside India
- Company Class: Private
- Listing Status: Unlisted
- Industry: Other Business Activities
- Date of AGM: 22 Sep 2015
🔒 14.3%
(FY 202_)🔒 8.9%
(FY 202_)🔒 12.7%
(FY 202_)🔒 9.5%
(FY 202_)🔒 11.8%
(FY 202_)🔒 15.2%
(FY 202_)🔒 10.6%
(FY 202_)🔒 13.4%
(FY 202_)
Financial Performance Overview
| Financial Metric | FY 2023 | Growth | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | 12,45,67,890 | +191.42% | 4,26,78,123 | 3,89,45,234 | 2,98,12,456 | 2,15,67,890 |
| Revenue from Operations | 11,98,45,678 | +176.82% | 4,32,10,987 | 3,78,90,123 | 2,89,45,678 | 2,10,23,456 |
| Total Assets | 45,67,89,012 | +61.07% | 28,34,56,789 | 24,56,78,901 | 19,87,65,432 | 16,54,32,109 |
| Profit or Loss | -1,23,45,678 | 24.56% | 4,32,109 | 2,15,678 | 1,89,234 | 1,23,456 |
| Net Worth | 12,34,56,789 | 85.66% | 85,67,89,012 | 78,90,12,345 | 65,43,21,098 | 54,32,10,987 |
| EBITDA | 2,34,56,789 | +6604.87% | 3,49,012 | 2,10,987 | 1,56,789 | 98,765 |
| Past Director Details of Shin Nippon Biomedical Laboratories India Private Limited |
|---|
Frequently Asked Questions
- amit agarwal
- suchi agarwal